BTLA and HVEM expression was confirmed on TILs and cancer cells in several types of tumors, including melanoma, hepatocellular carcinoma, colorectal cancer, glioblastoma, and others (63). This evidence concerns the gene TNFRSF14 and hepatocellular carcinoma.